Search details
1.
Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors.
BMC Cancer
; 23(1): 547, 2023 Jun 15.
Article
in English
| MEDLINE | ID: mdl-37322411
2.
Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation.
BMC Cancer
; 23(1): 1017, 2023 Oct 23.
Article
in English
| MEDLINE | ID: mdl-37867191
3.
Gemcitabine and cisplatin or oxaliplatin chemotherapy combined with atezolizumab plus bevacizumab for advanced biliary tract cancers: a single-arm trial.
Future Oncol
; 19(15): 1029-1035, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37132469
4.
Transarterial chemoembolization plus a PD-1 inhibitor with or without lenvatinib for intermediate-stage hepatocellular carcinoma.
Hepatol Res
; 52(8): 721-729, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35536197
5.
Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase II trial.
Future Oncol
; 18(30): 3367-3375, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35968836
6.
Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
J Gastroenterol Hepatol
; 34(7): 1214-1221, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-30402968
7.
Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
BMC Cancer
; 17(1): 902, 2017 12 28.
Article
in English
| MEDLINE | ID: mdl-29282010
8.
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.
Nat Med
; 30(3): 708-715, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38242982
9.
Percutaneous radiofrequency ablation versus partial hepatectomy for small centrally located hepatocellular carcinoma.
World J Surg
; 37(3): 602-7, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23212793
10.
Bellows stiffness characteristics of cord-reinforced air spring with winding formation under preload conditions.
Sci Rep
; 13(1): 3377, 2023 Feb 28.
Article
in English
| MEDLINE | ID: mdl-36854784
11.
Efficacy and safety of TACE combined with lenvatinib and PD-1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study.
Cancer Med
; 12(10): 11513-11524, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36999793
12.
Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study.
Therap Adv Gastroenterol
; 16: 17562848231160630, 2023.
Article
in English
| MEDLINE | ID: mdl-37007215
13.
Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study.
Front Immunol
; 14: 1107542, 2023.
Article
in English
| MEDLINE | ID: mdl-36875125
14.
Efficacy and safety of radiotherapy combined with atezolizumab plus bevacizumab in treating hepatocellular carcinoma with portal vein tumour thrombus: a study protocol.
BMJ Open
; 12(12): e064688, 2022 12 15.
Article
in English
| MEDLINE | ID: mdl-36521893
15.
Image-matching digital macro-slide-a novel pathological examination method for microvascular invasion detection in hepatocellular carcinoma.
Hepatol Int
; 16(2): 381-395, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35294742
16.
A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion.
Eur J Surg Oncol
; 48(6): 1348-1355, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34996665
17.
Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization Refractory.
Front Oncol
; 12: 839605, 2022.
Article
in English
| MEDLINE | ID: mdl-35387113
18.
Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world.
Front Oncol
; 12: 954203, 2022.
Article
in English
| MEDLINE | ID: mdl-36505818
19.
Prognostic Value of Microvascular Invasion in Eight Existing Staging Systems for Hepatocellular Carcinoma: A Bi-Centeric Retrospective Cohort Study.
Front Oncol
; 11: 726569, 2021.
Article
in English
| MEDLINE | ID: mdl-34976789
20.
In-hospital Mortality after Surgical Resection in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus.
J Cancer
; 10(1): 72-80, 2019.
Article
in English
| MEDLINE | ID: mdl-30662527